Target intelligence / Profile preview

Ribosomal protein L12 pseudogene 35 (RPL12P35)

Target
RPL12P35
Molecular classification
Other (Processed pseudogene)
01

Overview

Ribosomal protein L12 pseudogene 35 (RPL12P35) is a processed pseudogene corresponding to the ribosomal protein L12 gene. Pseudogenes are non-functional segments of DNA that resemble functional genes but generally do not produce active proteins. RPL12P35 itself is not known to encode a functional protein or play a direct role in biological processes or disease. Its presence is mostly relevant in the context of genome annotation and evolutionary studies. Confusion can arise because the functional ribosomal protein L12 (encoded by RPL12) is a component of the ribosome involved in protein synthesis[3][5], whereas RPL12P35 is simply one of many pseudogene copies of that gene found scattered in the human genome[4][2][8]. The functional ribosomal protein L12 (RPL12) is an essential ribosomal protein found in the 60S subunit, involved in protein translation and associated with certain diseases[3][5]. The pseudogene RPL12P35 does not encode an active protein and is not a valid drug target, receptor, enzyme, transporter, etc. Pseudogenes like RPL12P35 are mainly catalogued for genomics purposes; their function, if any, is rarely well established[8]. No evidence supports RPL12P35 as a biomarker, drug target, therapeutic risk, or biological actor. If you sought the functional ribosomal protein, RPL12 (ribosomal protein L12), those entries would differ substantially.

Other names
RPL12 pseudogene 35RPL12_13_1452
02

Mechanism of action

Not applicable; pseudogenes do not generally have mechanisms of action relevant to drug targeting

03

Biological functions

No known direct biological function; pseudogenes generally do not encode functional proteins
04

Disease associations

No established role in disease; most pseudogenes are not directly implicated in disease, though individual cases may exist for other pseudogenes
05

Safety considerations

No safety concerns; not a therapeutic target
06

Interacting drugs

No drugs known to interact with this pseudogene
07

Biomarkers

Not established as a biomarker

Beyond the preview

Go deeper on Ribosomal protein L12 pseudogene 35 (RPL12P35).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L12 pseudogene 35 (RPL12P35).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call